Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
25
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Blanchard Karl | Chief Operating Officer | 4 | $0 | $0 | 2017-03-31 |
| Minmier James | See Remarks | 4 | $0 | $0 | 2017-03-31 |
| Stanger William | See Remarks | 4 | $0 | $0 | 2017-03-31 |
| Baetz Cary D | CFO and Treasurer | 5 | $0 | $0 | 2017-03-31 |
| WINCHESTER JERRY L | President and CEO | 4 | $0 | $0 | 2017-03-31 |
| King David S | Director | 1 | $0 | $0 | 2016-09-23 |
| DiPaolo Edward John | Director | 1 | $0 | $0 | 2016-09-23 |
| HINCHMAN STEVEN B | Director | 1 | $0 | $0 | 2016-09-23 |
| WALL DOUGLAS JAMES | Director | 1 | $0 | $0 | 2016-09-23 |
| THOMPSON VIRGIL | Director | 3 | $0 | $2.1K | 2013-12-04 |
| JAEGER STEPHEN O | Director | 3 | $0 | $1.9K | 2013-10-17 |
| Bahrt Kenneth | SVP, Chief Medical Officer | 18 | $0 | $42.9K | 2013-10-16 |
| Constantine Ginger | Director | 3 | $0 | $616 | 2013-10-16 |
| Hamill John | SVP, CFO | 9 | $0 | $3.0K | 2013-10-15 |
| Gionco David | Group VP & Chief Acct. Officer | 7 | $0 | $5.3K | 2013-10-15 |
| CROWLEY Richard | EVP, Chief Operating Officer | 14 | $0 | $90.1K | 2013-10-15 |
| YACHMETZ PHILIP K | SVP, General Counsel | 16 | $0 | $60.5K | 2013-10-15 |
| FERRARI LOUIS | President and CEO | 19 | $0 | $75.1K | 2013-05-22 |
| Veitch David | President | 2 | $0 | $0 | 2013-03-05 |
| Meeker David P | Director | 2 | $0 | $0 | 2013-01-07 |
| Savage Robert G. | Director | 2 | $0 | $0 | 2012-12-05 |
| Norton David Y | Director | 2 | $0 | $0 | 2012-07-09 |
| Owen William F | Director | 2 | $0 | $0 | 2012-05-22 |
| ZUERBLIS KENNETH J | EVP, Chief Financial Officer | 1 | $0 | $0 | 2012-02-01 |
| JOHNSON JOHN | Chief Executive Officer | 1 | $0 | $40.6K | 2012-01-03 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Blanchard Karl | Chief Operating Officer | F Tax w/h | 2017-03-31 | 2017-04-04 | 7,747 | $42.73 | $331.0K | 217,519 | SEC↗ |
| Minmier James | See Remarks | F Tax w/h | 2017-03-31 | 2017-04-04 | 4,448 | $42.73 | $190.1K | 184,891 | SEC↗ |
| Baetz Cary D | CFO and Treasurer | F Tax w/h | 2017-03-31 | 2017-04-04 | 7,747 | $42.73 | $331.0K | 241,809 | SEC↗ |
| WINCHESTER JERRY L | President and CEO | F Tax w/h | 2017-03-31 | 2017-04-04 | 12,911 | $42.73 | $551.7K | 362,533 | SEC↗ |
| Stanger William | See Remarks | F Tax w/h | 2017-03-31 | 2017-04-04 | 3,559 | $42.73 | $152.1K | 149,147 | SEC↗ |
| Blanchard Karl | Chief Operating Officer | F Tax w/h | 2016-12-31 | 2017-01-10 | 7,747 | $45.00 | $348.6K | 225,266 | SEC↗ |
| WINCHESTER JERRY L | President and CEO | F Tax w/h | 2016-12-31 | 2017-01-10 | 12,911 | $45.00 | $581.0K | 375,444 | SEC↗ |
| Minmier James | See Remarks | F Tax w/h | 2016-12-31 | 2017-01-10 | 6,456 | $45.00 | $290.5K | 189,339 | SEC↗ |
| Baetz Cary D | CFO and Treasurer | F Tax w/h | 2016-12-31 | 2017-01-10 | 7,747 | $45.00 | $348.6K | 249,556 | SEC↗ |
| Stanger William | See Remarks | F Tax w/h | 2016-12-31 | 2017-01-10 | 5,165 | $45.00 | $232.4K | 152,706 | SEC↗ |
| WINCHESTER JERRY L | President and CEO | A Award | 2016-09-23 | 2016-09-27 | 440,000 | — | $0 | 440,000 | SEC↗ |
| WINCHESTER JERRY L | President and CEO | F Tax w/h | 2016-09-23 | 2016-09-27 | 51,645 | $17.31 | $894.0K | 388,355 | SEC↗ |
| King David S | Director | A Award | 2016-09-23 | 2016-09-27 | 12,998 | — | $0 | 12,998 | SEC↗ |
| DiPaolo Edward John | Director | A Award | 2016-09-23 | 2016-09-27 | 12,998 | — | $0 | 12,998 | SEC↗ |
| Stanger William | See Remarks | F Tax w/h | 2016-09-23 | 2016-09-27 | 18,129 | $17.31 | $313.8K | 157,871 | SEC↗ |
| Stanger William | See Remarks | A Award | 2016-09-23 | 2016-09-27 | 176,000 | — | $0 | 176,000 | SEC↗ |
| Baetz Cary D | CFO and Treasurer | F Tax w/h | 2016-09-23 | 2016-09-27 | 23,070 | $17.31 | $399.3K | 257,303 | SEC↗ |
| Baetz Cary D | CFO and Treasurer | A Award | 2016-09-23 | 2016-09-27 | 264,000 | — | $0 | 280,373 | SEC↗ |
| HINCHMAN STEVEN B | Director | A Award | 2016-09-23 | 2016-09-27 | 12,998 | — | $0 | 12,998 | SEC↗ |
| WALL DOUGLAS JAMES | Director | A Award | 2016-09-23 | 2016-09-27 | 12,998 | — | $0 | 12,998 | SEC↗ |
| Blanchard Karl | Chief Operating Officer | A Award | 2016-09-23 | 2016-09-27 | 264,000 | — | $0 | 264,000 | SEC↗ |
| Blanchard Karl | Chief Operating Officer | F Tax w/h | 2016-09-23 | 2016-09-27 | 30,987 | $17.31 | $536.4K | 233,013 | SEC↗ |
| Minmier James | See Remarks | A Award | 2016-09-23 | 2016-09-27 | 220,000 | — | $0 | 220,000 | SEC↗ |
| Minmier James | See Remarks | F Tax w/h | 2016-09-23 | 2016-09-27 | 24,205 | $17.31 | $419.0K | 195,795 | SEC↗ |
| Baetz Cary D | CFO and Treasurer | A Award | 2016-08-01 | 2016-09-27 | 16,373 | — | $0 | 16,373 | SEC↗ |
| THOMPSON VIRGIL | Director | S Sale | 2013-12-04 | 2013-12-05 | 106,751 | $0.02 | $2.1K | 0 | SEC↗ |
| JAEGER STEPHEN O | Director | S Sale | 2013-10-17 | 2013-10-18 | 38,061 | $0.05 | $1.9K | 0 | SEC↗ |
| Bahrt Kenneth | SVP, Chief Medical Officer | S Sale | 2013-10-16 | 2013-10-17 | 3,500 | $0.07 | $245 | 102,900 | SEC↗ |
| Bahrt Kenneth | SVP, Chief Medical Officer | S Sale | 2013-10-16 | 2013-10-17 | 1,600 | $0.07 | $112 | 106,400 | SEC↗ |
| Bahrt Kenneth | SVP, Chief Medical Officer | S Sale | 2013-10-16 | 2013-10-17 | 2,400 | $0.07 | $168 | 100,500 | SEC↗ |
| Bahrt Kenneth | SVP, Chief Medical Officer | S Sale | 2013-10-16 | 2013-10-17 | 500 | $0.07 | $35 | 100,000 | SEC↗ |
| Constantine Ginger | Director | S Sale | 2013-10-16 | 2013-10-21 | 8,805 | $0.07 | $616 | 0 | SEC↗ |
| Bahrt Kenneth | SVP, Chief Medical Officer | S Sale | 2013-10-15 | 2013-10-17 | 3,911 | $0.08 | $313 | 108,000 | SEC↗ |
| Bahrt Kenneth | SVP, Chief Medical Officer | S Sale | 2013-10-15 | 2013-10-17 | 65,639 | $0.08 | $5.3K | 112,572 | SEC↗ |
| Bahrt Kenneth | SVP, Chief Medical Officer | S Sale | 2013-10-15 | 2013-10-17 | 661 | $0.08 | $53 | 111,911 | SEC↗ |
| Gionco David | Chief Accounting Officer | S Sale | 2013-10-15 | 2013-10-17 | 10,000 | $0.08 | $800 | 35,764 | SEC↗ |
| Gionco David | Chief Accounting Officer | S Sale | 2013-10-15 | 2013-10-17 | 5,476 | $0.08 | $438 | 78,164 | SEC↗ |
| Gionco David | Chief Accounting Officer | S Sale | 2013-10-15 | 2013-10-17 | 3,000 | $0.08 | $240 | 66,664 | SEC↗ |
| Gionco David | Chief Accounting Officer | S Sale | 2013-10-15 | 2013-10-17 | 20,900 | $0.08 | $1.7K | 45,764 | SEC↗ |
| Gionco David | Chief Accounting Officer | S Sale | 2013-10-15 | 2013-10-17 | 8,500 | $0.08 | $680 | 69,664 | SEC↗ |
| CROWLEY Richard | Co-President and COO | S Sale | 2013-10-15 | 2013-10-17 | 11,165 | $0.08 | $893 | 274,325 | SEC↗ |
| CROWLEY Richard | Co-President and COO | S Sale | 2013-10-15 | 2013-10-17 | 102,575 | $0.08 | $8.2K | 171,750 | SEC↗ |
| Hamill John | Co-President and CFO | S Sale | 2013-10-15 | 2013-10-17 | 800 | $0.08 | $64 | 74,313 | SEC↗ |
| Hamill John | Co-President and CFO | S Sale | 2013-10-15 | 2013-10-17 | 1,000 | $0.08 | $80 | 75,113 | SEC↗ |
| Hamill John | Co-President and CFO | S Sale | 2013-10-15 | 2013-10-17 | 21,000 | $0.08 | $1.7K | 76,113 | SEC↗ |
| Hamill John | Co-President and CFO | S Sale | 2013-10-15 | 2013-10-17 | 7,646 | $0.08 | $612 | 66,667 | SEC↗ |
| Hamill John | Co-President and CFO | S Sale | 2013-10-15 | 2013-10-17 | 1,500 | $0.08 | $120 | 102,113 | SEC↗ |
| Hamill John | Co-President and CFO | S Sale | 2013-10-15 | 2013-10-17 | 5,000 | $0.08 | $400 | 97,113 | SEC↗ |
| YACHMETZ PHILIP K | Co-President and CBO | S Sale | 2013-10-15 | 2013-10-17 | 10,000 | $0.09 | $900 | 90,545 | SEC↗ |
| YACHMETZ PHILIP K | Co-President and CBO | S Sale | 2013-10-15 | 2013-10-17 | 20,000 | $0.10 | $2.0K | 283,701 | SEC↗ |
| YACHMETZ PHILIP K | Co-President and CBO | S Sale | 2013-10-15 | 2013-10-17 | 19,745 | $0.10 | $2.0K | 263,956 | SEC↗ |
| YACHMETZ PHILIP K | Co-President and CBO | S Sale | 2013-10-15 | 2013-10-17 | 20,000 | $0.09 | $1.8K | 243,956 | SEC↗ |
| YACHMETZ PHILIP K | Co-President and CBO | S Sale | 2013-10-15 | 2013-10-17 | 40,000 | $0.10 | $4.0K | 203,956 | SEC↗ |
| YACHMETZ PHILIP K | Co-President and CBO | S Sale | 2013-10-15 | 2013-10-17 | 53,411 | $0.10 | $5.3K | 100,545 | SEC↗ |
| YACHMETZ PHILIP K | Co-President and CBO | S Sale | 2013-10-15 | 2013-10-17 | 50,000 | $0.10 | $5.0K | 153,956 | SEC↗ |
| FERRARI LOUIS | President and CEO | S Sale | 2013-05-22 | 2013-05-23 | 1,020 | $0.57 | $581 | 307,439 | SEC↗ |
| CROWLEY Richard | EVP, Chief Operating Officer | S Sale | 2013-04-30 | 2013-05-01 | 2,485 | $0.74 | $1.8K | 285,490 | SEC↗ |
| Bahrt Kenneth | SVP, Chief Medical Officer | S Sale | 2013-04-30 | 2013-05-01 | 1,250 | $0.74 | $925 | 178,211 | SEC↗ |
| Gionco David | Group VP & Chief Acct. Offic | S Sale | 2013-03-06 | 2013-03-08 | 1,560 | $0.93 | $1.5K | 83,640 | SEC↗ |
| Bahrt Kenneth | SVP, Chief Medical Officer | A Award deriv | 2013-03-05 | 2013-03-07 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Bahrt Kenneth | SVP, Chief Medical Officer | A Award deriv | 2013-03-05 | 2013-03-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Bahrt Kenneth | SVP, Chief Medical Officer | A Award deriv | 2013-03-05 | 2013-03-07 | 110,000 | — | $0 | 110,000 | SEC↗ |
| CROWLEY Richard | EVP, Biopharmaceutical Ops | A Award deriv | 2013-03-05 | 2013-03-07 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CROWLEY Richard | EVP, Biopharmaceutical Ops | A Award deriv | 2013-03-05 | 2013-03-07 | 110,000 | — | $0 | 110,000 | SEC↗ |
| FERRARI LOUIS | President and CEO | A Award deriv | 2013-03-05 | 2013-03-07 | 180,000 | — | $0 | 180,000 | SEC↗ |
| FERRARI LOUIS | President and CEO | A Award deriv | 2013-03-05 | 2013-03-07 | 60,200 | — | $0 | 60,200 | SEC↗ |
| Hamill John | SVP, CFO | A Award deriv | 2013-03-05 | 2013-03-07 | 110,000 | — | $0 | 110,000 | SEC↗ |
| YACHMETZ PHILIP K | SVP, General Counsel | A Award deriv | 2013-03-05 | 2013-03-07 | 110,000 | — | $0 | 110,000 | SEC↗ |
| YACHMETZ PHILIP K | SVP, General Counsel | A Award deriv | 2013-03-05 | 2013-03-07 | 78,000 | — | $0 | 78,000 | SEC↗ |
| Veitch David | President | A Award deriv | 2013-03-05 | 2013-03-07 | 162,500 | — | $0 | 162,500 | SEC↗ |
| Veitch David | President | A Award deriv | 2013-03-05 | 2013-03-07 | 110,000 | — | $0 | 110,000 | SEC↗ |
| Gionco David | Group VP & Chief Acct. Offic | A Award | 2013-03-05 | 2013-03-07 | 29,000 | — | $0 | 85,200 | SEC↗ |
| FERRARI LOUIS | President and CEO | S Sale | 2013-02-25 | 2013-02-25 | 375 | $0.99 | $371 | 295,996 | SEC↗ |
| YACHMETZ PHILIP K | SVP, General Counsel | S Sale | 2013-02-04 | 2013-02-06 | 3,203 | $1.02 | $3.3K | 303,701 | SEC↗ |
| YACHMETZ PHILIP K | SVP, General Counsel | S Sale | 2013-02-04 | 2013-02-06 | 27,297 | $1.01 | $27.6K | 306,904 | SEC↗ |
| FERRARI LOUIS | President and CEO | S Sale | 2013-02-04 | 2013-02-06 | 59,000 | $1.01 | $59.6K | 299,571 | SEC↗ |
| FERRARI LOUIS | President and CEO | S Sale | 2013-02-04 | 2013-02-06 | 3,200 | $1.02 | $3.3K | 296,371 | SEC↗ |
| CROWLEY Richard | EVP, Biopharmaceutical Ops | S Sale | 2013-02-04 | 2013-02-06 | 30,000 | $1.05 | $31.5K | 287,975 | SEC↗ |
| CROWLEY Richard | EVP, Biopharmaceutical Ops | S Sale | 2013-02-04 | 2013-02-06 | 18,900 | $1.01 | $19.1K | 317,975 | SEC↗ |
| Bahrt Kenneth | SVP, Chief Medical Officer | S Sale | 2013-02-04 | 2013-02-06 | 21,700 | $1.04 | $22.6K | 171,750 | SEC↗ |
| Bahrt Kenneth | SVP, Chief Medical Officer | S Sale | 2013-02-04 | 2013-02-06 | 7,300 | $1.01 | $7.4K | 193,450 | SEC↗ |
| CROWLEY Richard | EVP, Biopharmaceutical Ops | S Sale | 2013-01-31 | 2013-02-04 | 2,415 | $1.02 | $2.5K | 336,875 | SEC↗ |
| Bahrt Kenneth | SVP, Chief Medical Officer | S Sale | 2013-01-31 | 2013-02-04 | 1,300 | $1.03 | $1.3K | 200,750 | SEC↗ |
| YACHMETZ PHILIP K | SVP, General Counsel | S Sale | 2013-01-14 | 2013-01-16 | 1,283 | $1.14 | $1.5K | 334,201 | SEC↗ |
| Meeker David P | Director | A Award deriv | 2013-01-07 | 2013-01-17 | 16,415 | $1.17 | $19.2K | 16,415 | SEC↗ |
| Meeker David P | Director | A Award | 2013-01-07 | 2013-01-17 | 12,644 | $1.17 | $14.8K | 12,644 | SEC↗ |
| Savage Robert G. | Director | A Award deriv | 2012-12-05 | 2012-12-07 | 21,013 | $1.14 | $24.0K | 21,013 | SEC↗ |
| Savage Robert G. | Director | A Award | 2012-12-05 | 2012-12-07 | 16,149 | $1.14 | $18.4K | 16,149 | SEC↗ |
| FERRARI LOUIS | President and CEO | S Sale | 2012-11-26 | 2012-11-27 | 950 | $1.16 | $1.1K | 358,571 | SEC↗ |
| Bahrt Kenneth | SVP, Chief Medical Officer | S Sale | 2012-10-31 | 2012-11-06 | 1,000 | $1.45 | $1.4K | 202,050 | SEC↗ |
| CROWLEY Richard | EVP, Biopharmaceutical Ops | S Sale | 2012-10-31 | 2012-11-06 | 2,010 | $1.45 | $2.9K | 339,290 | SEC↗ |
| Hamill John | SVP, CFO | A Award deriv | 2012-09-24 | 2012-09-26 | 250,000 | $2.92 | $730.0K | 250,000 | SEC↗ |
| Hamill John | SVP, CFO | A Award | 2012-09-24 | 2012-09-26 | 100,000 | $2.92 | $292.0K | 100,000 | SEC↗ |
| FERRARI LOUIS | President and CEO | A Award | 2012-08-31 | 2012-11-27 | 2,434 | $1.12 | $2.7K | 359,521 | SEC↗ |
| FERRARI LOUIS | President and CEO | S Sale | 2012-08-22 | 2012-08-24 | 984 | $1.00 | $984 | 348,577 | SEC↗ |
| CROWLEY Richard | EVP, Biopharma Operatiotions | S Sale | 2012-08-02 | 2012-08-03 | 2,500 | $0.62 | $1.6K | 341,300 | SEC↗ |
| Bahrt Kenneth | SVP, Chief Medical Officer | S Sale | 2012-08-01 | 2012-08-03 | 4,950 | $0.62 | $3.1K | 203,050 | SEC↗ |
| FERRARI LOUIS | President and CEO | A Award deriv | 2012-07-09 | 2013-03-07 | 150,000 | — | $0 | 150,000 | SEC↗ |
| FERRARI LOUIS | President and CEO | A Award deriv | 2012-07-09 | 2012-07-11 | 150,000 | $0.56 | $84.0K | 150,000 | SEC↗ |
| Norton David Y | Director | A Award deriv | 2012-07-09 | 2012-07-20 | 82,458 | $0.56 | $46.2K | 82,458 | SEC↗ |
| Norton David Y | Director | A Award | 2012-07-09 | 2012-07-20 | 62,035 | $0.56 | $34.7K | 69,284 | SEC↗ |
| FERRARI LOUIS | President and CEO | A Award | 2012-05-31 | 2012-11-27 | 5,888 | $0.62 | $3.7K | 357,087 | SEC↗ |
| Constantine Ginger | Director | A Award deriv | 2012-05-22 | 2012-05-24 | 69,728 | $0.81 | $56.5K | 69,728 | SEC↗ |
| THOMPSON VIRGIL | Director | A Award deriv | 2012-05-22 | 2012-05-24 | 69,728 | $0.81 | $56.5K | 69,728 | SEC↗ |
| Owen William F | Director | A Award deriv | 2012-05-22 | 2012-05-24 | 69,728 | $0.81 | $56.5K | 69,728 | SEC↗ |
| JAEGER STEPHEN O | Director | A Award deriv | 2012-05-22 | 2012-05-24 | 139,456 | $0.81 | $113.0K | 139,456 | SEC↗ |
| FERRARI LOUIS | EVP, North American Commeric | S Sale | 2012-05-22 | 2012-05-22 | 942 | $0.82 | $772 | 349,561 | SEC↗ |
| Constantine Ginger | Director | A Award | 2012-05-22 | 2012-05-24 | 49,382 | $0.81 | $40.0K | 65,015 | SEC↗ |
| THOMPSON VIRGIL | Director | A Award | 2012-05-22 | 2012-05-24 | 49,382 | $0.81 | $40.0K | 109,575 | SEC↗ |
| Owen William F | Director | A Award | 2012-05-22 | 2012-05-24 | 49,382 | $0.81 | $40.0K | 56,631 | SEC↗ |
| JAEGER STEPHEN O | Director | A Award | 2012-05-22 | 2012-05-24 | 98,765 | $0.81 | $80.0K | 165,410 | SEC↗ |
| CROWLEY Richard | EVP Biopharmaceutical Operat | S Sale | 2012-05-01 | 2012-05-01 | 9,200 | $2.35 | $21.6K | 343,800 | SEC↗ |
| CROWLEY Richard | EVP, Biopharmaceutical Ops | A Award deriv | 2012-03-05 | 2013-03-07 | 25,000 | — | $0 | 25,000 | SEC↗ |
| FERRARI LOUIS | President and CEO | A Award | 2012-02-29 | 2012-11-27 | 2,622 | $1.71 | $4.5K | 351,199 | SEC↗ |
| YACHMETZ PHILIP K | SVP, General Counsel | A Award | 2012-02-27 | 2012-02-29 | 100,000 | $2.10 | $210.0K | 335,484 | SEC↗ |
| FERRARI LOUIS | EVP, North American Commeric | S Sale | 2012-02-22 | 2012-02-23 | 4,100 | $2.06 | $8.4K | 350,503 | SEC↗ |
| YACHMETZ PHILIP K | SVP, General Counsel | S Sale | 2012-02-14 | 2012-02-23 | 3,540 | $2.02 | $7.2K | 235,484 | SEC↗ |
| FERRARI LOUIS | EVP, N American Commerical O | A Award deriv | 2012-02-01 | 2012-02-13 | 100,000 | $2.26 | $226.0K | 100,000 | SEC↗ |
| ZUERBLIS KENNETH J | EVP, Chief Financial Officer | A Award deriv | 2012-02-01 | 2012-02-13 | 100,000 | $2.26 | $226.0K | 100,000 | SEC↗ |
| YACHMETZ PHILIP K | SVP, General Counsel | A Award deriv | 2012-02-01 | 2012-02-13 | 100,000 | $2.26 | $226.0K | 100,000 | SEC↗ |
| CROWLEY Richard | EVP, Biopharmaceutical Ops | A Award deriv | 2012-02-01 | 2012-02-13 | 100,000 | $2.26 | $226.0K | 100,000 | SEC↗ |
| Bahrt Kenneth | SVP, Chief Medical Officer | A Award deriv | 2012-02-01 | 2012-02-13 | 100,000 | $2.26 | $226.0K | 100,000 | SEC↗ |
| FERRARI LOUIS | EVP, N American Commerical O | A Award | 2012-02-01 | 2012-02-13 | 310,000 | $2.26 | $700.6K | 354,603 | SEC↗ |
| YACHMETZ PHILIP K | SVP, General Counsel | A Award | 2012-02-01 | 2012-02-13 | 50,000 | $2.26 | $113.0K | 239,024 | SEC↗ |
| CROWLEY Richard | EVP, Biopharmaceutical Ops | A Award | 2012-02-01 | 2012-02-13 | 250,000 | $2.26 | $565.0K | 353,000 | SEC↗ |
| Bahrt Kenneth | SVP, Chief Medical Officer | A Award | 2012-02-01 | 2012-02-13 | 150,000 | $2.26 | $339.0K | 208,000 | SEC↗ |
| JOHNSON JOHN | Chief Executive Officer | S Sale | 2012-01-03 | 2012-01-04 | 17,650 | $2.30 | $40.6K | 252,350 | SEC↗ |
| FERRARI LOUIS | EVP, N American Commerical O | A Award | 2011-11-30 | 2012-02-13 | 381 | $2.13 | $812 | 44,603 | SEC↗ |
| FERRARI LOUIS | EVP, N American Commerical O | A Award | 2011-08-31 | 2012-02-13 | 222 | $3.66 | $813 | 44,222 | SEC↗ |